title: Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Marzia
authors.initials: M
authors.lastname: Varettoni
authors.affiliation: Fondazione IRCCS C. Mondino, Institute of Neurology, Pavia, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Marchioni
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bonfichi
authors.affiliation: Fondazione IRCCS C. Mondino, Institute of Neurology, Pavia, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Picchiecchio
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.|Department of Molecular Medicine, University of Pavia, Pavia, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Arcaini
authors.affiliation: Division of Neurology, Ospedale Civile Di Voghera, Italy.
authors.forename: Carla
authors.initials: C
authors.lastname: Arbasino
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Manuel
authors.initials: M
authors.lastname: Gotti
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Da Vià
authors.affiliation: Radiology and Neuroradiology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Mariella
authors.initials: M
authors.lastname: Delmonte
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Sciarra
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.|Department of Molecular Medicine, University of Pavia, Pavia, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Cazzola
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012074:Remission Induction; D000069283:Rituximab; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride